First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults
首次人体随机研究，旨在评估基于黑猩猩腺病毒-155病毒载体的呼吸道合胞病毒（RSV）研究疫苗在健康成年人中的安全性和免疫原性，该疫苗表达RSV融合蛋白、核衣壳蛋白和抗终止蛋白。
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciz653
Cicconi, Paola; Jones, Claire; Sarkar, Esha; Silva-Reyes, Laura; Klenerman, Paul; de Lara, Catherine; Hutchings, Claire; Moris, Philippe; Janssens, Michel; Fissette, Laurence A; Picciolato, Marta; Leach, Amanda; Gonzalez-Lopez, Antonio; Dieussaert, Ilse; Snape, Matthew D
